Company Filing History:
3 out of 541 
Years Active: 2018-2024
Title: Innovations of Peter Cariuk
Introduction
Peter Cariuk is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic binding molecules and antibodies, holding a total of 4 patents. His work focuses on addressing critical health issues, particularly in the realm of inflammatory diseases and cancer treatment.
Latest Patents
Among his latest patents, one invention relates to therapeutic binding molecules that specifically target the chemokine receptor CCR9. This invention is particularly relevant for the treatment of CCR9-mediated diseases, such as inflammatory bowel disease (IBD). Another significant patent involves antibodies directed against GDF-15, which can be utilized in detecting human GDF-15 and in treating conditions like cancer and body weight loss associated with the over-expression of this protein.
Career Highlights
Peter Cariuk is currently associated with Medimmune Limited, where he continues to innovate and develop new therapeutic solutions. His work has the potential to impact many lives by providing new treatment options for serious health conditions.
Collaborations
Peter has collaborated with esteemed colleagues, including Andrew Grier Buchanan and Matthieu Chodorge, to advance his research and patent developments.
Conclusion
Peter Cariuk's contributions to the field of therapeutic binding molecules and antibodies highlight his role as a significant inventor in modern medicine. His innovative work continues to pave the way for new treatments and advancements in healthcare.